Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01010334 · ClinicalTrials.gov registry record · NA

Comparison of Standard of Care or Treatment on Protocol

A NA study, sponsored by New Mexico Cancer Research Alliance.

Terminated
Registry status
NA
Development phase
13
Enrollment target

NCT01010334: Clinical Trial NA study, sponsored by New Mexico Cancer Research Alliance.

NCT01010334 is a NA study that was terminated before completion, run by New Mexico Cancer Research Alliance. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01010334, a NA study, was terminated before completion, sponsored by New Mexico Cancer Research Alliance.

TERMINATED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

Patient will choose to either receive the standard of care according to National Comprehensive Cancer Network (NCCN) or approved guidelines for their condition or to be treated according to one arm of the protocol that they could not be enrolled on. The selection of the arm will be at physician discretion.

Interventions

  • OTHER standard of care

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2009-03
Est. Completion 2011-07
Phase NA

Why NCT01010334 stopped before completion

NCT01010334 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which standard of care is the first listed.

NCT01010334 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01010334 about?

NCT01010334 is a clinical study titled "Comparison of Standard of Care or Treatment on Protocol". Patient will choose to either receive the standard of care according to National Comprehensive Cancer Network (NCCN) or approved guidelines for their condition or to be treated according to one arm of the protocol that they could not be enrolled on. The selection of the arm will be at physician disc...

What is the current status of trial NCT01010334?

This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2009-03. Estimated completion is 2011-07.

What interventions are being tested in trial NCT01010334?

The interventions under investigation include: standard of care (OTHER).

Who is sponsoring clinical trial NCT01010334?

This trial is sponsored by New Mexico Cancer Research Alliance, which has 66 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01010334's enrollment target sits among peer trials

13 1911th of 2000 higher than 88 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01010334, the US trial registry maintained by the National Library of Medicine. NCT01010334 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.